Primary goal achieved: Immutep reports strong Phase II results in sarcoma trial
26 May 2025 - Strong results in soft tissue sarcoma have capped off a busy quarter of immunotherapy progress
26May
13May
How Etherstack is powering global emergency networks
13 May 2025 - Mission-critical communications with global expansion potential.
13May
Volatility as opportunity: VanEck’s smarter beta bets
13 May 2025 - Cameron Cormack, Senior Portfolio Manager at VanEck, on ETF strategy and market outlook
12May
Understanding credit investing with AL Capital
12 May 2025 - Phil Smith, a Director at AL Capital, discusses the company's strategy and focus on capital protection.
12May
BluGlass eyes growth with defence and US laser tech deals
12 May 2025 - Chairman James Walker discusses funding, contracts, and commercial momentum for 2025.
23Apr
Bringing next-generation batteries to market
23 Apr 2025 - The road to commercialisation: Overcoming funding and regulatory hurdles in battery storage
21Apr
The road to drug approval: Challenges and strategies
21 Apr 2025 - Navigating the FDA Process and Clinical Trial Hurdles
16Apr
Property, credit, and long-term value: Inside Capital Prudential’s playbook
16 Apr 2025 - Managing Director Jarrad Haynes shares how the firm is navigating risk, scaling development, and positioning for long-term growth.
09Apr
Building a battery supply chain that lasts: Lessons from Altech
09 Apr 2025 - Martin Stein discusses the supply chain, environmental, and ethical challenges of lithium-ion batteries and the benefits of Altech’s alternative
07Apr
Bringing immunotherapies to market: From approval to commercial success
07 Apr 2025 - The Final Steps in Drug Development and Market Access